tiprankstipranks
Crescent Biopharma (CBIO)
NASDAQ:CBIO

Compare Crescent Biopharma (CBIO) vs. Competitors

1,023 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Crescent Biopharma
$18.17
$500.71M
-8.24
-6.63%
5 Buy
0 Hold
0 Sell
Strong Buy
Compugen
$2.58
$243.95M
4.04
113.22%
3 Buy
0 Hold
0 Sell
Strong Buy
Fate Therapeutics
$1.24
$144.17M
-0.86
32.62%
0 Buy
3 Hold
0 Sell
Hold
Orchestra BioMed Holdings
$4.13
$241.69M
6.38
58.85%
5 Buy
1 Hold
0 Sell
Strong Buy
Fractyl Health, Inc.
$0.46
$72.98M
-51.43%
3 Buy
1 Hold
0 Sell
Strong Buy
Actuate Therapeutics, Inc.
$1.72
$40.78M
-7.81
-75.81%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CBIO
Crescent Biopharma
18.17
-4.03
-18.15%
CGEN
Compugen
2.58
1.27
96.95%
FATE
Fate Therapeutics
1.24
0.32
34.20%
OBIO
Orchestra BioMed Holdings
4.13
1.33
47.50%
GUTS
Fractyl Health, Inc.
0.46
-0.53
-53.54%
ACTU
Actuate Therapeutics, Inc.
1.72
-6.28
-78.50%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts